Humana Inc. (NYSE:HUM)
Market Cap | 65.07B |
---|---|
Revenue | 95.64B |
Gross Profit | 95.64B |
Shares Out | 124.94M |
EPS (ttm) | 24.6 |
PE Ratio | 20.8889 |
Forward PE | 18.5460 |
Dividend Rate (ttm) | 3.2395 |
Dividend Yield | 0.0062 |
Trading Day | Jun 2 |
---|---|
Last Price | $520.78 |
Previous Close | $515.15 |
Change ($) | 5.63 |
Change (%) | 1.09% |
Day's Open | 514.36 |
Day's Range | 512.56 - 523.005 |
Day's Volume | 785.20K |
52 Week Range | 415.92 - 569.39 |
About Humana Inc.
at humana, our cultural foundation is aligned to helping members achieve their best health by delivering personalized, simplified, whole-person healthcare experiences. recognizing healthcare needs continue to evolve for each person, for each family and for each community, humana continuously creates innovative solutions and resources that help people live their healthiest lives on their terms –when and where they need it.
our employees are at the heart of making this happen and that’s why we are dedicated to building an organization of dynamic talent whose experience and passion center on putting the customer first.
News
Quick info
Louisville
Kentucky
40202-2946
Humana Inc. income statements (2023) (USD)
April 2023 | |
---|---|
Total Revenue | 26.74B |
Cost of Revenue | 0 |
Gross Profit | 26.74B |
Research & Development | 0 |
Selling General & Admin | 0 |
Operating Expense | 25.02B |
Operating Income | 1.72B |
Other Income Expense Net | 0 |
EBIT | 1.70B |
Interest Income | 113M |
Pretax Income | 1.60B |
Income Tax | 359M |
Minority Interest | -1M |
Net Income | 1.24B |
Net Income Basic | 1.24B |
Humana Inc. income statements (2022) (USD)
July 2022 | July 2022 | April 2022 | February 2022 | |
---|---|---|---|---|
Total Revenue | 23.66B | 23.66B | 23.97B | 21.05B |
Cost of Revenue | 0 | 0 | 0 | 0 |
Gross Profit | 23.66B | 23.66B | 23.97B | 21.05B |
Research & Development | 0 | 0 | 0 | 0 |
Selling General & Admin | 0 | 0 | 0 | 0 |
Operating Expense | 22.45B | 22.45B | 22.68B | 20.99B |
Operating Income | 1.22B | 1.22B | 1.29B | 61M |
Other Income Expense Net | 0 | 0 | 0 | 0 |
EBIT | 1.22B | 1.22B | 1.29B | 57M |
Interest Income | 101M | 101M | 90M | 91M |
Pretax Income | 1.12B | 1.12B | 1.22B | -64M |
Income Tax | 427M | 427M | 286M | -51M |
Minority Interest | 1M | 1M | 0 | 1M |
Net Income | 696M | 696M | 0.93B | -14M |
Net Income Basic | 696M | 696M | 0.93B | -14M |
Humana Inc. income statements (2021) (USD)
November 2021 | July 2021 | April 2021 | February 2021 | |
---|---|---|---|---|
Total Revenue | 20.70B | 20.65B | 20.67B | 19.06B |
Cost of Revenue | 0 | 0 | 0 | 0 |
Gross Profit | 20.70B | 20.65B | 20.67B | 19.06B |
Research & Development | 0 | 0 | 0 | 0 |
Selling General & Admin | 0 | 0 | 0 | 0 |
Operating Expense | 20.07B | 19.41B | 19.45B | 19.41B |
Operating Income | 628M | 1.24B | 1.22B | -346M |
Other Income Expense Net | 0 | 0 | 0 | 0 |
EBIT | 643M | 1.27B | 1.24B | -340M |
Interest Income | 88M | 79M | 68M | 72M |
Pretax Income | 1.65B | 771M | 1.06B | -452M |
Income Tax | 120M | 183M | 233M | -178M |
Minority Interest | 0 | 0 | 0 | 0 |
Net Income | 1.53B | 588M | 828M | -274M |
Net Income Basic | 1.53B | 588M | 828M | -274M |
Humana Inc. income statements (2020) (USD)
November 2020 | June 2020 | June 2020 | March 2020 | March 2020 | |
---|---|---|---|---|---|
Total Revenue | 20.08B | N.A | N.A | N.A | N.A |
Cost of Revenue | 0 | N.A | N.A | N.A | N.A |
Gross Profit | 20.08B | N.A | N.A | N.A | N.A |
Research & Development | 0 | N.A | N.A | N.A | N.A |
Selling General & Admin | 0 | N.A | N.A | N.A | N.A |
Operating Expense | 18.25B | N.A | N.A | N.A | N.A |
Operating Income | 1.82B | N.A | N.A | N.A | N.A |
Other Income Expense Net | 0 | N.A | N.A | N.A | N.A |
EBIT | 1.86B | N.A | N.A | N.A | N.A |
Interest Income | 75M | 76M | 76M | 60M | 60M |
Pretax Income | 1.79B | 2.59B | 2.59B | 717M | 717M |
Income Tax | 450M | 783M | 783M | 252M | 252M |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Net Income | 1.34B | 1.83B | 1.83B | 473M | 473M |
Net Income Basic | 1.34B | 1.83B | 1.83B | 473M | 473M |
Humana Inc. income statements (2019) (USD)
December 2019 | September 2019 | June 2019 | March 2019 | |
---|---|---|---|---|
Total Revenue | N.A | N.A | N.A | N.A |
Cost of Revenue | N.A | N.A | N.A | N.A |
Gross Profit | N.A | N.A | N.A | N.A |
Research & Development | N.A | N.A | N.A | N.A |
Selling General & Admin | N.A | N.A | N.A | N.A |
Operating Expense | N.A | N.A | N.A | N.A |
Operating Income | N.A | N.A | N.A | N.A |
Other Income Expense Net | N.A | N.A | N.A | N.A |
EBIT | N.A | N.A | N.A | N.A |
Interest Income | 58M | 62M | 60M | 62M |
Pretax Income | 593M | 888M | 1.23B | 746M |
Income Tax | 79M | 200M | 301M | 183M |
Minority Interest | 0 | 0 | 0 | 0 |
Net Income | 512M | 689M | 0.94B | 566M |
Net Income Basic | 512M | 689M | 0.94B | 566M |
Humana Inc. income statements (2018) (USD)
December 2018 | September 2018 | June 2018 | March 2018 | |
---|---|---|---|---|
Total Revenue | N.A | N.A | N.A | N.A |
Cost of Revenue | N.A | N.A | N.A | N.A |
Gross Profit | N.A | N.A | N.A | N.A |
Research & Development | N.A | N.A | N.A | N.A |
Selling General & Admin | N.A | N.A | N.A | N.A |
Operating Expense | N.A | N.A | N.A | N.A |
Operating Income | N.A | N.A | N.A | N.A |
Other Income Expense Net | N.A | N.A | N.A | N.A |
EBIT | N.A | N.A | N.A | N.A |
Interest Income | 59M | 53M | 53M | 53M |
Pretax Income | 436M | 0.90B | 19M | 707M |
Income Tax | 83M | 266M | -174M | 216M |
Minority Interest | 0 | 0 | 0 | 0 |
Net Income | 355M | 644M | 193M | 491M |
Net Income Basic | 355M | 644M | 193M | 491M |
Humana Inc. income statements (2017) (USD)
December 2017 | September 2017 | June 2017 | |
---|---|---|---|
Total Revenue | N.A | N.A | N.A |
Cost of Revenue | N.A | N.A | N.A |
Gross Profit | N.A | N.A | N.A |
Research & Development | N.A | N.A | N.A |
Selling General & Admin | N.A | N.A | N.A |
Operating Expense | N.A | N.A | N.A |
Operating Income | N.A | N.A | N.A |
Other Income Expense Net | N.A | N.A | N.A |
EBIT | N.A | N.A | N.A |
Interest Income | 76M | 59M | 58M |
Pretax Income | 490M | 799M | 1.04B |
Income Tax | 306M | 300M | 392M |
Minority Interest | 0 | 0 | 0 |
Net Income | 184M | 499M | 650M |
Net Income Basic | 184M | 499M | 650M |
Humana Inc. balance sheet (2023) (USD)
April 2023 | |
---|---|
Current Cash | 0 |
Receivables | 3.11B |
Inventory | 0 |
Current Assets | 37.53B |
Other Current Assets | 5.76B |
Short Term Investments | 20.69B |
Long Term Investments | 17.24B |
Property/Plant Equipment | 3.23B |
Good Will | N.A |
Intangible Assets | 0 |
Tangible Assets (Net) | 7.26B |
Other Assets | 3.95B |
Total Assets | 54.78B |
Accounts Payable | 0 |
Other Current Liabilities | 24.67B |
Total Current Liabilities | 26.94B |
Total Liabilities | 38.20B |
Long Term Debt | 9.74B |
Current Long Term Debt | 2.27B |
Minority Interest | 57M |
Common Stock | 125.01M |
Treasury Stock | -12.22B |
Retained Earnings | 26.62B |
Capital Surplus | N.A |
Shareholder Equity | 16.58B |
Other Liabilities | N.A |
Humana Inc. balance sheet (2022) (USD)
July 2022 | July 2022 | April 2022 | February 2022 | |
---|---|---|---|---|
Current Cash | 0 | 0 | 0 | 0 |
Receivables | 3.37B | 3.37B | 3.17B | 1.81B |
Inventory | 0 | 0 | 0 | 0 |
Current Assets | 27.22B | 27.22B | 26.84B | 24.89B |
Other Current Assets | 5.66B | 5.66B | 5.71B | 6.49B |
Short Term Investments | 18.70B | 18.70B | 18.80B | 19.69B |
Long Term Investments | 19.60B | 19.60B | 19.47B | 19.47B |
Property/Plant Equipment | 3.12B | 3.12B | 3.19B | 3.07B |
Good Will | N.A | N.A | N.A | N.A |
Intangible Assets | 0 | 0 | 0 | 0 |
Tangible Assets (Net) | 6.58B | 6.58B | 4.18B | 4.99B |
Other Assets | 7.40B | 7.40B | 5B | 5.16B |
Total Assets | 46.82B | 46.82B | 46.31B | 44.36B |
Accounts Payable | 0 | 0 | 0 | 0 |
Other Current Liabilities | 15.91B | 15.91B | 15.53B | 13.05B |
Total Current Liabilities | 17.84B | 17.84B | 17.53B | 15.33B |
Total Liabilities | 31.33B | 31.33B | 30.99B | 28.28B |
Long Term Debt | 11.29B | 11.29B | 11.29B | 10.54B |
Current Long Term Debt | 1.93B | 1.93B | 2.01B | 2.28B |
Minority Interest | 20M | 20M | 23M | 23M |
Common Stock | 126.52M | 126.52M | 126.94M | 128.61M |
Treasury Stock | -11.16B | -11.16B | -11.16B | -10.16B |
Retained Earnings | 24.51B | 24.51B | 23.92B | 23.09B |
Capital Surplus | N.A | N.A | N.A | N.A |
Shareholder Equity | 15.49B | 15.49B | 15.32B | 16.08B |
Other Liabilities | N.A | N.A | N.A | N.A |
Humana Inc. balance sheet (2021) (USD)
November 2021 | July 2021 | April 2021 | February 2021 | |
---|---|---|---|---|
Current Cash | 0 | 0 | 0 | 0 |
Receivables | 1.88B | 2.44B | 2.20B | 1.14B |
Inventory | 0 | 0 | 0 | 0 |
Current Assets | 25.82B | 25.79B | 25.53B | 23.64B |
Other Current Assets | 5.91B | 6.50B | 6.20B | 5.28B |
Short Term Investments | 19.63B | 19.97B | 19.45B | 17.83B |
Long Term Investments | 19.51B | 12.28B | 11.89B | 11.33B |
Property/Plant Equipment | 2.90B | 2.69B | 2.51B | 2.37B |
Good Will | N.A | N.A | N.A | N.A |
Intangible Assets | 0 | 0 | 0 | 0 |
Tangible Assets (Net) | 5.45B | 9.93B | 9.59B | 9.28B |
Other Assets | 5.66B | 3.44B | 3.58B | 3.34B |
Total Assets | 45.32B | 38.07B | 37.42B | 34.97B |
Accounts Payable | 0 | 0 | 0 | 0 |
Other Current Liabilities | 13.99B | 13.71B | 13.75B | 12.47B |
Total Current Liabilities | 15.03B | 15.05B | 15.30B | 13.39B |
Total Liabilities | 29.06B | 23.23B | 23.23B | 21.24B |
Long Term Debt | 11.47B | 6.06B | 6.06B | 6.06B |
Current Long Term Debt | 1.04B | 1.35B | 1.55B | 0.92B |
Minority Interest | 22M | 0 | 0 | 0 |
Common Stock | 128.52M | 128.69M | 128.93M | 132.10M |
Treasury Stock | -10.17B | -10.18B | -9.92B | -9.92B |
Retained Earnings | 23.19B | 21.75B | 21.25B | 20.52B |
Capital Surplus | N.A | N.A | N.A | N.A |
Shareholder Equity | 16.26B | 14.84B | 14.19B | 13.73B |
Other Liabilities | N.A | N.A | N.A | N.A |
Humana Inc. balance sheet (2020) (USD)
November 2020 | June 2020 | June 2020 | March 2020 | March 2020 | |
---|---|---|---|---|---|
Current Cash | 0 | N.A | N.A | N.A | N.A |
Receivables | 1.14B | N.A | N.A | N.A | N.A |
Inventory | 0 | N.A | N.A | N.A | N.A |
Current Assets | 27.03B | 27.87B | 27.87B | 19.17B | 19.17B |
Other Current Assets | 5.17B | 5.63B | 5.63B | N.A | N.A |
Short Term Investments | 17.91B | 12.84B | 12.84B | 11.10B | 11.10B |
Long Term Investments | 11.45B | 1.12B | 1.12B | 1.09B | 1.09B |
Property/Plant Equipment | 2.23B | 2.12B | 2.12B | 2.02B | 2.02B |
Good Will | N.A | N.A | N.A | N.A | N.A |
Intangible Assets | 0 | 374M | 374M | 396M | 396M |
Tangible Assets (Net) | 11.33B | 9.97B | 9.97B | 2.40B | 2.40B |
Other Assets | 2.51B | 7.77B | 7.77B | 7.12B | 7.12B |
Total Assets | 38.48B | 38.46B | 38.46B | 34.63B | 34.63B |
Accounts Payable | 0 | 6.18B | 6.18B | 5.40B | 5.40B |
Other Current Liabilities | 12.97B | 8.56B | 8.56B | 7.26B | 7.26B |
Total Current Liabilities | 14.91B | 16.46B | 16.46B | 14.56B | 14.56B |
Total Liabilities | 22.71B | 24.04B | 24.04B | 22.28B | 22.28B |
Long Term Debt | 6.06B | 6.06B | 6.06B | 6.06B | 6.06B |
Current Long Term Debt | 1.94B | N.A | N.A | N.A | N.A |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Common Stock | 2.97B | 132.29M | 132.29M | 132.21M | 132.21M |
Treasury Stock | -8.45B | 8.45B | 8.45B | 8.45B | 8.45B |
Retained Earnings | 20.87B | 19.62B | 19.62B | 17.87B | 17.87B |
Capital Surplus | N.A | 2.90B | 2.90B | 2.86B | 2.86B |
Shareholder Equity | 15.77B | 14.42B | 14.42B | 12.36B | 12.36B |
Other Liabilities | N.A | N.A | N.A | N.A | N.A |
Humana Inc. balance sheet (2019) (USD)
December 2019 | September 2019 | June 2019 | March 2019 | |
---|---|---|---|---|
Current Cash | N.A | N.A | N.A | N.A |
Receivables | N.A | N.A | N.A | N.A |
Inventory | N.A | N.A | N.A | N.A |
Current Assets | 16.94B | 16.81B | 15.67B | 15.71B |
Other Current Assets | N.A | N.A | N.A | N.A |
Short Term Investments | 10.97B | 10.43B | 9.99B | 9.88B |
Long Term Investments | 1.06B | 1.06B | 1.06B | 1.05B |
Property/Plant Equipment | 2.37B | 2.27B | 2.20B | 2.17B |
Good Will | N.A | N.A | N.A | N.A |
Intangible Assets | 177M | 194M | 211M | 228M |
Tangible Assets (Net) | 3.35B | 2.93B | 3.20B | 2.22B |
Other Assets | 4.79B | 4.53B | 5.44B | 4.88B |
Total Assets | 29.31B | 29.18B | 28.91B | 28.35B |
Accounts Payable | 3.64B | 3.52B | 3.71B | 3.60B |
Other Current Liabilities | 6.11B | 6.37B | 5.93B | 6.06B |
Total Current Liabilities | 10.57B | 10.71B | 11.11B | 11.49B |
Total Liabilities | 17.27B | 17.58B | 17.04B | 17.51B |
Long Term Debt | 5.30B | 5.69B | 4.70B | 4.70B |
Current Long Term Debt | N.A | N.A | N.A | N.A |
Minority Interest | 0 | 0 | 0 | 0 |
Common Stock | 132.11M | 132.43M | 135.09M | 135.04M |
Treasury Stock | 8.46B | 8.26B | 7.47B | 7.47B |
Retained Earnings | 17.48B | 17.05B | 16.43B | 15.56B |
Capital Surplus | 2.82B | 2.61B | 2.76B | 2.72B |
Shareholder Equity | 12.04B | 11.60B | 11.87B | 10.84B |
Other Liabilities | N.A | N.A | N.A | N.A |
Humana Inc. balance sheet (2018) (USD)
December 2018 | September 2018 | June 2018 | March 2018 | |
---|---|---|---|---|
Current Cash | N.A | N.A | N.A | N.A |
Receivables | N.A | N.A | N.A | N.A |
Inventory | N.A | N.A | N.A | N.A |
Current Assets | 13.89B | 14.90B | 22.45B | 19.87B |
Other Current Assets | N.A | N.A | 3.47B | N.A |
Short Term Investments | 10.03B | 9.70B | 9.46B | 9.74B |
Long Term Investments | 1.05B | 1.05B | N.A | N.A |
Property/Plant Equipment | 1.74B | 1.69B | 1.63B | 1.60B |
Good Will | N.A | N.A | N.A | N.A |
Intangible Assets | 245M | 263M | 284M | 276M |
Tangible Assets (Net) | 1.54B | 1.98B | 1.59B | 1.73B |
Other Assets | 4.38B | 5.30B | 9.10B | 5.59B |
Total Assets | 25.66B | 27.49B | 34.27B | 33.45B |
Accounts Payable | 3.07B | 5.41B | 6.95B | 6.27B |
Other Current Liabilities | 5.03B | 5.22B | 7.79B | 5.09B |
Total Current Liabilities | 9.79B | 11.03B | 15.14B | 11.75B |
Total Liabilities | 15.50B | 16.90B | 24.06B | 23.37B |
Long Term Debt | 4.38B | 4.77B | 4.77B | 4.77B |
Current Long Term Debt | N.A | N.A | N.A | N.A |
Minority Interest | 0 | 0 | 0 | 0 |
Common Stock | 135.57M | 137.19M | 137.76M | 137.68M |
Treasury Stock | 7.32B | 6.73B | 6.53B | 6.51B |
Retained Earnings | 15.07B | 14.79B | 14.21B | 14.09B |
Capital Surplus | 2.54B | 2.71B | 2.67B | 2.63B |
Shareholder Equity | 10.16B | 10.59B | 10.21B | 10.08B |
Other Liabilities | N.A | N.A | N.A | N.A |
Humana Inc. balance sheet (2017) (USD)
December 2017 | September 2017 | June 2017 | |
---|---|---|---|
Current Cash | N.A | N.A | N.A |
Receivables | N.A | N.A | N.A |
Inventory | N.A | N.A | N.A |
Current Assets | 15.38B | 19.41B | 18.68B |
Other Current Assets | N.A | N.A | N.A |
Short Term Investments | 9.56B | 8.62B | 8.12B |
Long Term Investments | N.A | N.A | N.A |
Property/Plant Equipment | 1.58B | 1.56B | 1.54B |
Good Will | N.A | N.A | N.A |
Intangible Assets | 226M | 227M | 245M |
Tangible Assets (Net) | 2.51B | 3.90B | 3.64B |
Other Assets | 3.85B | 5.76B | 5.83B |
Total Assets | 27.51B | 32.96B | 32.25B |
Accounts Payable | 4.07B | 4.89B | 4.69B |
Other Current Liabilities | 4.81B | 5.13B | 4.96B |
Total Current Liabilities | 9.03B | 10.97B | 10.35B |
Total Liabilities | 17.67B | 21.75B | 21.30B |
Long Term Debt | 4.77B | 3.98B | 4.28B |
Current Long Term Debt | N.A | N.A | N.A |
Minority Interest | 0 | 0 | 0 |
Common Stock | 137.68M | 142.86M | 144.52M |
Treasury Stock | 6.33B | 5.02B | 4.48B |
Retained Earnings | 13.67B | 13.54B | 13.10B |
Capital Surplus | 2.45B | 2.64B | 2.31B |
Shareholder Equity | 9.84B | 11.21B | 10.95B |
Other Liabilities | N.A | N.A | N.A |
Humana Inc. cash flow (2023) (USD)
April 2023 | February 2023 | |
---|---|---|
Net Income | 1.24B | -15M |
Depreciation | 218M | 217M |
Changes in Receivables | 3.11B | 1.67B |
Changes in Inventories | 0 | 0 |
Cash Change | 13.74B | 5.06B |
Cash Flow | 6.69B | -5.13B |
Capital Expenditures | -223M | -258M |
Investments | N.A | N.A |
Investing Activity (other) | N.A | N.A |
Total Investing Cash Flows | -1.29B | -1.01B |
Dividends Paid | N.A | N.A |
Net Borrowings | -8.67B | -8.02B |
Other Financing Cash Flows | N.A | N.A |
Cash Flow Financing | 3.28B | -2.36B |
Exchange Rate Effect | N.A | N.A |
Humana Inc. cash flow (2022) (USD)
November 2022 | July 2022 | |
---|---|---|
Net Income | 1.20B | 696M |
Depreciation | 214M | 209M |
Changes in Receivables | 1.61B | 3.37B |
Changes in Inventories | 0 | 0 |
Cash Change | 13.56B | 5.15B |
Cash Flow | 8.45B | 0.96B |
Capital Expenditures | -288M | -279M |
Investments | N.A | N.A |
Investing Activity (other) | N.A | N.A |
Total Investing Cash Flows | 1.68B | -1.02B |
Dividends Paid | N.A | N.A |
Net Borrowings | -7.71B | -5.47B |
Other Financing Cash Flows | N.A | N.A |
Cash Flow Financing | -1.79B | 419M |
Exchange Rate Effect | N.A | N.A |
Humana Inc. cash flow (2021) (USD)
November 2021 | |
---|---|
Net Income | 1.53B |
Depreciation | 181M |
Changes in Receivables | 1.88B |
Changes in Inventories | 0 |
Cash Change | 4.30B |
Cash Flow | 1.88B |
Capital Expenditures | -326M |
Investments | N.A |
Investing Activity (other) | N.A |
Total Investing Cash Flows | -4.25B |
Dividends Paid | N.A |
Net Borrowings | -7.13B |
Other Financing Cash Flows | N.A |
Cash Flow Financing | 2.34B |
Exchange Rate Effect | N.A |
Humana Inc. cash flow (2020) (USD)
November 2020 | June 2020 | March 2020 | |
---|---|---|---|
Net Income | 1.34B | 1.83B | 473M |
Depreciation | 456M | 150M | 145M |
Changes in Receivables | -1.1B | N.A | N.A |
Changes in Inventories | 0 | N.A | N.A |
Cash Change | 822M | 1.11B | 2B |
Cash Flow | 5.36B | 3.07B | 474M |
Capital Expenditures | -668M | -226M | -192M |
Investments | N.A | -1.43B | -309M |
Investing Activity (other) | N.A | N.A | N.A |
Total Investing Cash Flows | -3.01B | -1.65B | -1.21B |
Dividends Paid | N.A | -83M | -73M |
Net Borrowings | -9.91B | -179M | 2.29B |
Other Financing Cash Flows | N.A | -45M | 519M |
Cash Flow Financing | 1.59B | -306M | 2.74B |
Exchange Rate Effect | N.A | N.A | N.A |
Humana Inc. cash flow (2019) (USD)
December 2019 | September 2019 | June 2019 | March 2019 | |
---|---|---|---|---|
Net Income | 512M | 689M | 0.94B | 566M |
Depreciation | 140M | 159M | 140M | 136M |
Changes in Receivables | N.A | N.A | N.A | N.A |
Changes in Inventories | N.A | N.A | N.A | N.A |
Cash Change | -1.47B | 749M | 0.90B | 1.53B |
Cash Flow | 512M | 2.44B | 1.43B | 896M |
Capital Expenditures | -230M | -210M | -157M | -139M |
Investments | -571M | -356M | 101M | 284M |
Investing Activity (other) | N.A | N.A | N.A | N.A |
Total Investing Cash Flows | -801M | -566M | -56M | 145M |
Dividends Paid | -75M | -74M | -74M | -68M |
Net Borrowings | -402M | 335M | -373M | 17M |
Other Financing Cash Flows | -682M | -393M | -31M | 537M |
Cash Flow Financing | -1.18B | -1.13B | -477M | 493M |
Exchange Rate Effect | N.A | N.A | N.A | N.A |
Humana Inc. cash flow (2018) (USD)
December 2018 | September 2018 | June 2018 | March 2018 | |
---|---|---|---|---|
Net Income | 355M | 644M | 193M | 491M |
Depreciation | 134M | 131M | 130M | 139M |
Changes in Receivables | N.A | N.A | N.A | N.A |
Changes in Inventories | N.A | N.A | N.A | N.A |
Cash Change | -1.8B | -4.69B | -24M | 4.81B |
Cash Flow | -333M | -1.06B | -125M | 3.69B |
Capital Expenditures | -176M | -164M | -138M | -134M |
Investments | -271M | -1.38B | 441M | -102M |
Investing Activity (other) | N.A | N.A | N.A | N.A |
Total Investing Cash Flows | -447M | -2.35B | 118M | -405M |
Dividends Paid | -70M | -69M | -69M | -57M |
Net Borrowings | 895M | -3M | -2M | 245M |
Other Financing Cash Flows | -1.05B | -1.01B | 64M | 1.38B |
Cash Flow Financing | -1.02B | -1.28B | -17M | 1.53B |
Exchange Rate Effect | N.A | N.A | N.A | N.A |
Humana Inc. cash flow (2017) (USD)
December 2017 | September 2017 | June 2017 | |
---|---|---|---|
Net Income | 184M | 499M | 650M |
Depreciation | 128M | 120M | 119M |
Changes in Receivables | N.A | N.A | N.A |
Changes in Inventories | N.A | N.A | N.A |
Cash Change | -5.82B | 1.73B | -286M |
Cash Flow | -2.91B | 2.86B | -106M |
Capital Expenditures | -150M | -143M | -111M |
Investments | -1B | -554M | -39M |
Investing Activity (other) | N.A | N.A | N.A |
Total Investing Cash Flows | -1.17B | -698M | -152M |
Dividends Paid | -58M | -58M | -57M |
Net Borrowings | 35M | 3M | -338M |
Other Financing Cash Flows | -179M | -150M | 351M |
Cash Flow Financing | -1.75B | -439M | -28M |
Exchange Rate Effect | N.A | N.A | N.A |
Humana Inc. dividends (USD)
Ex date | Payment date | Record date | Declared date | Amount | Description | Frequency |
---|---|---|---|---|---|---|
30-03-2023 | 28-04-2023 | 31-03-2023 | N.A | 0.89 | Ordinary Shares | Quarterly |
29-12-2022 | 27-01-2023 | 30-12-2022 | N.A | 0.79 | Ordinary Shares | Quarterly |
29-09-2022 | 28-10-2022 | 30-09-2022 | N.A | 0.79 | Ordinary Shares | Quarterly |
29-06-2022 | 29-07-2022 | 30-06-2022 | N.A | 0.79 | Ordinary Shares | Quarterly |
29-09-2021 | 29-10-2021 | 30-09-2021 | N.A | 0.70 | Ordinary Shares | Quarterly |
30-12-2020 | 07-01-2021 | 31-12-2020 | N.A | 0.01 | Etf Growth And Income Port September USD Ser 2020 MNT CASH | Blank |
29-09-2020 | 30-10-2020 | 30-09-2020 | N.A | 0.63 | Ordinary Shares | Quarterly |
29-06-2020 | 31-07-2020 | 30-06-2020 | N.A | 0.63 | Ordinary Shares | Quarterly |
30-03-2020 | 24-04-2020 | 31-03-2020 | N.A | 0.63 | Ordinary Shares | Quarterly |
30-03-2020 | 24-04-2020 | 31-03-2020 | N.A | 0.63 | Ordinary Shares | Quarterly |
30-12-2019 | 31-01-2020 | 31-12-2019 | N.A | 0.55 | Ordinary Shares | Quarterly |
27-09-2019 | 25-10-2019 | 30-09-2019 | N.A | 0.55 | Ordinary Shares | Quarterly |
27-06-2019 | 26-07-2019 | 28-06-2019 | N.A | 0.55 | Ordinary Shares | Quarterly |
28-03-2019 | 26-04-2019 | 29-03-2019 | N.A | 0.55 | Ordinary Shares | Quarterly |
28-12-2018 | 25-01-2019 | 31-12-2018 | N.A | 0.50 | Ordinary Shares | Quarterly |
27-09-2018 | 26-10-2018 | 28-09-2018 | N.A | 0.50 | Ordinary Shares | Quarterly |
28-06-2018 | 27-07-2018 | 29-06-2018 | N.A | 0.50 | Ordinary Shares | Quarterly |
28-03-2018 | 27-04-2018 | 30-03-2018 | N.A | 0.50 | Ordinary Shares | Quarterly |
28-12-2017 | 26-01-2018 | 29-12-2017 | N.A | 0.40 | Ordinary Shares | Quarterly |
28-09-2017 | 27-10-2017 | 29-09-2017 | N.A | 0.40 | Ordinary Shares | Quarterly |
28-06-2017 | 31-07-2017 | 30-06-2017 | N.A | 0.40 | Ordinary Shares | Quarterly |
29-03-2017 | 28-04-2017 | 31-03-2017 | N.A | 0.40 | Ordinary Shares | Quarterly |
10-01-2017 | 27-01-2017 | 12-01-2017 | N.A | 0.29 | Ordinary Shares | Quarterly |
11-10-2016 | 28-10-2016 | 13-10-2016 | N.A | 0.29 | Ordinary Shares | Quarterly |
28-06-2016 | 29-07-2016 | 30-06-2016 | N.A | 0.29 | Ordinary Shares | Quarterly |
29-03-2016 | 29-04-2016 | 31-03-2016 | N.A | 0.29 | Ordinary Shares | Quarterly |
28-12-2015 | 29-01-2016 | 30-12-2015 | N.A | 0.29 | Ordinary Shares | Quarterly |
28-09-2015 | 30-10-2015 | 30-09-2015 | N.A | 0.29 | Ordinary Shares | Quarterly |
26-06-2015 | 31-07-2015 | 30-06-2015 | N.A | 0.29 | Ordinary Shares | Quarterly |
Total Valuation
Humana Inc. has a market cap or net worth of $65.07 billion. The enterprise value is $77.08 billion.
Important Dates
Share Statistics
Humana Inc. has 124.94 million shares outstanding.
Valuation Ratios
The trailing PE ratio is 20.8889 and the forward PE ratio is 18.5460. Humana Inc.'s PEG ratio is 4.6751.
Stock Price Statistics
The stock price has increased by 0.0186%. The beta is 0.3707, so Humana Inc.'s price volatility has been lower than the market average.
Income Statement
In the last 12 months, Humana Inc. had revenue of $95.64 billion and earned $95.64 billion in profits. Earnings per share was $24.6.